Nektar Therapeutics
NKTR
#4696
Rank
โ‚น219.44 B
Marketcap
โ‚น6,427
Share price
-1.84%
Change (1 day)
23.88%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -โ‚น13.64 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚น55.63 Million. In 2025 the company made an earning of -โ‚น14.9 Billion a decrease over its 2024 earnings that were of -โ‚น11.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น13.64 Billion-8.48%
2025 -โ‚น14.9 Billion30.44%
2024 -โ‚น11.42 Billion-56.85%
2023 -โ‚น26.47 Billion-24.31%
2022 -โ‚น34.97 Billion-30.25%
2021 -โ‚น50.13 Billion17.87%
2020 -โ‚น42.53 Billion0.88%
2019 -โ‚น42.16 Billion-164.46%
2018 โ‚น65.39 B-810.61%
2017 -โ‚น9.21 Billion-37.06%
2016 -โ‚น14.63 Billion89.22%
2015 -โ‚น7.73 Billion48.22%
2014 -โ‚น5.22 Billion-65.93%
2013 -โ‚น15.31 Billion-6.81%
2012 -โ‚น16.43 Billion28.95%
2011 -โ‚น12.74 Billion258.8%
2010 -โ‚น3.55 Billion-63.94%
2009 -โ‚น9.85 Billion-392.45%
2008 โ‚น3.36 B-211.74%
2007 -โ‚น3.02 Billion-79.57%
2006 -โ‚น14.75 Billion-16.9%
2005 -โ‚น17.75 Billion81.53%
2004 -โ‚น9.78 Billion54.19%
2003 -โ‚น6.34 Billion-33.87%
2002 -โ‚น9.59 Billion-9.6%
2001 -โ‚น10.61 Billion73.39%
2000 -โ‚น6.12 Billion108.9%
1999 -โ‚น2.93 Billion39.48%
1998 -โ‚น2.1 Billion60.02%
1997 -โ‚น1.32 Billion18.05%
1996 -โ‚น1.12 Billion31.82%
1995 -โ‚น0.85 Billion57.14%
1994 -โ‚น0.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.488 T-17,168.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.014 T-7,058.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น870.42 B-6,070.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น48.67 Billion 233.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.259 T-8,740.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.404 T-9,734.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น0.50 B-103.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น22.72 B-255.84%๐Ÿ‡ฎ๐Ÿ‡ช Ireland